Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chiari Malformation Type 2”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Early research (Phase 1)Study completedNCT00659893
What this trial is testing

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Who this might be right for
Actinic Keratosis
Peplin 64
Testing effectiveness (Phase 2)Study completedNCT01922050
What this trial is testing

Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 320
Early research (Phase 1)Study completedNCT01761526
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 50
Large-scale testing (Phase 3)WithdrawnNCT03024060
What this trial is testing

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT02762253
What this trial is testing

Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.

Who this might be right for
Keratoconus
Nvision Laser Eye Centers 320
Early research (Phase 1)Study completedNCT00791856
What this trial is testing

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Who this might be right for
Healthy
Warner Chilcott 110
Testing effectiveness (Phase 2)Study completedNCT00427050
What this trial is testing

Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel

Who this might be right for
Actinic Keratoses
Peplin 50
Post-approval studies (Phase 4)Study completedNCT00116649
What this trial is testing

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Who this might be right for
Keratosis
Graceway Pharmaceuticals, LLC 551
Testing effectiveness (Phase 2)Study completedNCT02120456
What this trial is testing

Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 224
Early research (Phase 1)Study completedNCT02124239
What this trial is testing

Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions

Who this might be right for
Actinic Keratosis
LEO Pharma 79
Early research (Phase 1)Study completedNCT01964573
What this trial is testing

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

Who this might be right for
Parkinson's Disease
UCB Pharma 48
Not applicableStudy completedNCT04105192
What this trial is testing

Effectiveness of a Natural Ingredient on Obesity

Who this might be right for
Overweight and ObesityHigh Blood Pressure
Universidad Católica San Antonio de Murcia 84
Not applicableActive Not RecruitingNCT03090633
What this trial is testing

Fetoscopic Repair of Isolated Fetal Spina Bifida

Who this might be right for
Spina BifidaMyelomeningoceleChiari Malformation Type 2+3 more
Johns Hopkins University 30
Early research (Phase 1)Study completedNCT03575780
What this trial is testing

Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratoses
Athenex, Inc. 18
Large-scale testing (Phase 3)Study completedNCT02361216
What this trial is testing

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Who this might be right for
Actinic Keratosis
LEO Pharma 729
Large-scale testing (Phase 3)Study completedNCT01737762
What this trial is testing

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Who this might be right for
Venous Leg Ulcers
Healthpoint 155
Large-scale testing (Phase 3)Study completedNCT01222559
What this trial is testing

Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects

Who this might be right for
Articular Cartilage Lesion of the Femoral Condyle
co.don AG 102
Early research (Phase 1)Study completedNCT00292227
What this trial is testing

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 130
Large-scale testing (Phase 3)Study completedNCT00428389
What this trial is testing

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 262
Testing effectiveness (Phase 2)Study completedNCT01998984
What this trial is testing

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 266
Next Page